EntryPoint Capital’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,620
Closed -$103K 956
2024
Q3
$103K Buy
+20,620
New +$103K 0.06% 554